| http://www.w3.org/ns/prov#value | - Furthermore, cannabinoid agonists targeting CB1 receptors, including candidates being developed for pain reli...FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD)...needed for patients being transferred from systemically active corticosteroids to inhaled corticosteroids.
|
